Pharmacokinetic properties of lutein emulsion after oral administration to rats and effect of food intake on plasma concentration of lutein

Biopharmaceutics and Drug Disposition

Volumn 32, Issue 3, 2011, Pages 151-158

  Sato, Yuki ^a   Kobayashi, Masaki ^a   Itagaki, Shirou ^a   Hirano, Takeshi ^a,c   Noda, Toshihiro ^a   Mizuno, Satoshi ^b   Sugawara, Mitsuru ^a   Iseki, Ken ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JARD Inc 2 7   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Absorption; Bioavailability; Carotenoid; Lutein

Indexed keywords

BILE ACID; CHOLESTEROL; XANTHOPHYLL;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; EMULSION; FOOD DRUG INTERACTION; FOOD INTAKE; INTESTINE ABSORPTION; INTESTINE MUCOSA; LIPOPHILICITY; MALE; NONHUMAN; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; EATING; EMULSIONS; LUTEIN; MALE; RATS; RATS, WISTAR;

EID: 79953689276     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.746     Document Type: Article

References (31)

1. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr 1999; 70: 517-524. (Pubitemid 29463446)
2. Larssin SC, Bergkvist L, Näslund I, Rutegård J, Wolk A. Vitamin A, retinol, and carotenoids and the risk of gastric cancer: a prospective cohort study. Am J Clin Nutr 2007; 85: 497-503. (Pubitemid 46220954)
3. Zhang M, Holman CD, Binns CW. Intake of specific carotenoids and the risk of epithelial ovarian cancer. Br J Nutr 2007; 98: 187-193. (Pubitemid 47272164)
4. Granado F, Olmedilla B, Blanco I, Rojas-Hidalgo E. Major fruit and vegetable contributors to the main serum carotenoids in the Spanish diet. Eur J Clin Nutr 1996; 50: 246-250. (Pubitemid 26123952)
5. Sommerberg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are source for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 1998; 82: 907-910. (Pubitemid 28408149)
6. Granado F, Olmedilla B, Blanco I. Nutritional and clinical relevance of lutein in human health. Br J Nutr 2003; 90: 487-502. (Pubitemid 37168346)
7. Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997; 64: 211-218. (Pubitemid 27139567)
8. Trevithick-Sutton CC, Foote CS, Collins M, Trevithick JR. The retinal carotenoids zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: a chemiluminescence and ESR study. Mol Vis 2006; 12: 1127-1135. (Pubitemid 44480567)
9. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128. (Pubitemid 121003917)
10. Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem 1997; 272: 19633-19636. (Pubitemid 27340047)
11. Beatty S, Boulton M, Henson D, Koh HH, Murray IJ. Macular pigment and age related macular degeneration. Br J Ophthalmol 1999; 83: 867-877. (Pubitemid 29324801)
12. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol 2001; 153: 424-432. (Pubitemid 32185079)
13. Moeller SM, Parekh N, Tinker L, et al. Association between intermediate aged-related macular degeneration and lutein and zeaxanthin in the carotenoids in age related eye disease study. Arch Ophthalmol 2006; 124: 1151-1162. (Pubitemid 44232345)
14. Klein R, Klein BE, Jenson SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: The national health and nutrition examination survey III. Ophthalmology 1999; 106: 1056-1065. (Pubitemid 30191505)
15. Broekmans WM, Berendschot TT, Klöpping-Ketelaars IA, et al. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 2002; 76: 595-603. (Pubitemid 34920837)
16. Wang W, Connor SL, Johnson EJ, Klein ML, Hughes S, Connor WE. Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr 2007; 85: 762-769. (Pubitemid 46393508)
17. Fine SL, Berger JW, Maguire MG, Ho AL. Age-related macular degeneration. N Engl J Med 2000; 342: 483-492. (Pubitemid 30100237)
18. Izumi-Nagai K, Nagai N, Ohgami K, et al. Macular pigment lutein is anti-inflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 2007; 27: 2555-2565.
19. Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv 2007; 4: 403-416. (Pubitemid 47249138)
20. Itagaki S, Chiba M, Shimamoto S, et al. Characterization of secretory intestinal transport of phenolsulfonphthalein. Drug Metab Pharmacokinet 2005; 20: 72-78.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. Ochiai A, Itagaki S, Kurokawa T, Kobayashi M, Hirano T, Iseki K. Improvement in intestinal coenzyme Q10 absorption by food intake. Yakugaku Zasshi 2007; 127: 1251-1254. (Pubitemid 47204004)
23. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003; 23: 171-201. (Pubitemid 37059721)
24. Itagaki S, Ochiai A, Kobayashi M, Sugawara M, Hirano T, Iseki K. Interaction of coenzyme Q10 with the intestinal drug transporter P-glycoprotein. J Agric Food Chem 2008; 56: 6923-6927.
25. Hussain MM. A proposed model for the assembly of chylomicrons. Atherosclerosis 2000; 148: 1-15.
26. Liu CS, Glahn RP, Liu RH. Assessment of carotenoid bioavailability of whole foods using a Caco-2 cell culture model coupled with an in vitro digestion. J Agric Food Chem 2004; 52: 4330-4337.
27. Sugawara T, Kushiro M, Zhang H, Nara E, Ono H, Nagao A. Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells. J Nutr 2001; 131: 2921-2927. (Pubitemid 33063124)
28. Dial EJ, Rooijakkers SH, Darling RL, Romero JJ, Lichtenberger LM. Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes. J Gastroenterol Hepatol 2008; 23: 430-436. (Pubitemid 351342070)
29. Chen Y, Lu Y, Chen J, et al. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 2009; 376: 153-160.
30. Potluri P, Betageri G. Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone. Drug Deliv 2006; 13: 227-232.
31. Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6: 231-248. (Pubitemid 46344627)